WO2025233915 - USE OF AN AGONIST OF FORMYL PEPTIDE RECEPTORS 1 AND 2 FOR TREATING OCULAR INFLAMMATORY DISEASES
National phase entry is expected:
Publication Number
WO/2025/233915
Publication Date
13.11.2025
International Application No.
PCT/IB2025/054913
International Filing Date
09.05.2025
Title **
[English]
USE OF AN AGONIST OF FORMYL PEPTIDE RECEPTORS 1 AND 2 FOR TREATING OCULAR INFLAMMATORY DISEASES
[French]
UTILISATION D'UN AGONISTE DES RÉCEPTEURS 1 ET 2 DES PEPTIDES FORMYLES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES OCULAIRES
Applicants **
ALLGENESIS BIOTHERAPEUTICS INC.
LAI, Ching-Yu
CHERUKURY, Madhu
PATEL, Sunil
Inventors
NGUYEN, Tan
Priority Data
18/661,074
10.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2245 | |
| EPO | Filing, Examination, Granting | 11904 | |
| Japan | Filing, Examination, Granting | 2420 | |
| South Korea | Filing, Examination, Granting | 2459 | |
| USA | Filing, Examination, Granting | 5140 |
Total:
24,168
Contact Us
Abstract[English]
Pharmaceutical compositions containing AG-80308 and cyclodextrin are provided. Also provided are methods for treating ocular inflammatory diseases in a subject in need of such treatment by administering pharmaceutical compositions containing AG-80308 and cyclodextrin. Compositions may be formulated for ophthalmic application, for example, for ocular delivery, such as eye drops, to subjects in need thereof.[French]
L'invention concerne des compositions pharmaceutiques contenant de l'AG-80308 et de la cyclodextrine. L'invention concerne également des méthodes de traitement de maladies inflammatoires oculaires chez un sujet ayant besoin d'un tel traitement, par administration de compositions pharmaceutiques contenant de l'AG-80308 et de la cyclodextrine. Les compositions peuvent être formulées pour une application ophtalmique, par exemple pour une administration oculaire, telle que des gouttes pour les yeux, à des sujets en ayant besoin.